Differences in dynamic diurnal blood pressure variability between Japanese and American Treatment-Resistant hypertensive populations

Circulation Journal

Volumn 81, Issue 9, 2017, Pages 1337-1345

  Kario, Kazuomi ^a   Bhatt, Deepak L ^b   Brar, Sandeep ^c   Bakris, George L ^d  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MEDTRONIC INC   (United States)

^d UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Americans; Ethnicity; Japanese; Morning nighttime surge; Resistant hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AMERICAN; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; BODY MASS; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; CONTROLLED STUDY; ETHNICITY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PULSE RATE; RACE DIFFERENCE; RESISTANT HYPERTENSION; RETROSPECTIVE STUDY; SLEEP DISORDERED BREATHING; SYSTOLIC BLOOD PRESSURE; AGED; BLOOD PRESSURE; CLINICAL TRIAL; COMPARATIVE STUDY; HYPERTENSION; JAPAN; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; UNITED STATES;

ADULT; AGED; BLOOD PRESSURE; BODY MASS INDEX; CIRCADIAN RHYTHM; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; JAPAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SLEEP APNEA, OBSTRUCTIVE; UNITED STATES;

EID: 85025162619     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-16-1237     Document Type: Article

References (42)

1. Dodt C, Breckling U, Derad I, Fehm HL, Born J. Plasma epinephrine and norepinephrine concentrations of healthy humans associated with nighttime sleep and morning arousal. Hypertension 1997; 30: 71-76.
2. Panza JA, Epstein SE, Quyyumi AA. Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity. N Engl J Med 1991; 325: 986-990.
3. Kario K. Essential manual of 24 hour blood pressure management: From morning to nocturnal hypertension. Wiley-Blackwell, 2015.
4. Kario K, Ishikawa J, Pickering TG, Hoshide S, Eguchi K, Morinari M, et al. Morning hypertension: The strongest independent risk factor for stroke in elderly hypertensive patients. Hypertens Res 2006; 29: 581-587.
5. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: A prospective study. Circulation 2003; 107: 1401-1406.
6. Ishikawa J, Hoshide S, Eguchi K, Ishikawa S, Shimada K, Kario K. Nighttime home blood pressure and the risk of hypertensive target organ damage. Hypertension 2012; 60: 921-928.
7. Kario K, Saito I, Kushiro T, Teramukai S, Ishikawa Y, Mori Y, et al. Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy: Primary results of HONEST, a large-scale prospective, real-world observational study. Hypertension 2014; 64: 989-996.
8. Hoshide S, Yano Y, Haimoto H, Yamagiwa K, Uchiba K, Nagasaka S, et al. Morning and evening home blood pressure and risks of incident stroke and coronary artery disease in the Japanese general practice population: The Japan Morning Surge-Home Blood Pressure Study. Hypertension 2016; 68: 54-61.
9. Bombelli M, Fodri D, Toso E, Macchiarulo M, Cairo M, Facchetti R, et al. Relationship among morning blood pressure surge, 24-hour blood pressure variability, and cardiovascular outcomes in a white population. Hypertension 2014; 64: 943-950.
10. Suh M, Barksdale DJ, Logan JG. Morning blood pressure surge and nighttime blood pressure in relation to nocturnal sleep pattern and arterial stiffness. J Cardiovasc Nurs 2014; 29: E10-E17.
11. Chaturvedi N, Fuller JH. Ethnic differences in mortality from cardiovascular disease in the UK: Do they persist in people with diabetes? J Epidemiol Community Health 1996; 50: 137-139.
12. Clark LT, Ferdinand KC, Flack JM, Gavin JR III, Hall WD, Kumanyika SK, et al. Coronary heart disease in African Americans. Heart Dis 2001; 3: 97-108.
13. Flack JM, Bhatt DL, Kandzari DE, Brown D, Brar S, Choi JW, et al. An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trial. J Am Soc Hypertens 2015; 9: 769-779.
14. Mensah GA, Mokdad AH, Ford ES, Greenlund KJ, Croft JB. State of disparities in cardiovascular health in the United States. Circulation 2005; 111: 1233-1241.
15. Giles T, Aranda JM Jr, Suh DC, Choi IS, Preblick R, Rocha R, et al. Ethnic/racial variations in blood pressure awareness, treatment, and control. J Clin Hypertens (Greenwich) 2007; 9: 345-354.
16. Pan WH, Flegal KM, Chang HY, Yeh WT, Yeh CJ, Lee WC. Body mass index and obesity-related metabolic disorders in Taiwanese and US whites and blacks: Implications for definitions of overweight and obesity for Asians. Am J Clin Nutr 2004; 79: 31-39.
17. Wen CP, David Cheng TY, Tsai SP, Chan HT, Hsu HL, Hsu CC, et al. Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians. Public Health Nutr 2009; 12: 497-506.
18. Hoshide S, Kario K, de la Sierra A, Bilo G, Schillaci G, Banegas JR, et al. Ethnic differences in the degree of morning blood pressure surge and in its determinants between Japanese and European hypertensive subjects: Data from the ARTEMIS study. Hypertension 2015; 66: 750-756.
19. Parati G, Liu X, Ochoa JE, Bilo G. Prognostic relevance of blood pressure variability: Role of long-term and very long-term blood pressure changes. Hypertension 2013; 62: 682-684.
20. Verdecchia P, Angeli F, Mazzotta G, Garofoli M, Ramundo E, Gentile G, et al. Day-night dip and early-morning surge in blood pressure in hypertension: Prognostic implications. Hypertension 2012; 60: 34-42.
21. Bhatt DL, Kandzari DE, O’Neill WW, D’Agostino R, Flack JM, Katzen BT, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014; 370: 1393-1401.
22. Kario K, Ogawa H, Okumura K, Okura T, Saito S, Ueno T, et al. SYMPLICITY HTN-Japan: First randomized controlled trial of catheter-based renal denervation in Asian patients. Circ J 2015; 79: 1222-1229.
23. Bakris GL, Townsend RR, Liu M, Cohen SA, D’Agostino R, Flack JM, et al. Impact of renal denervation on 24-hour ambulatory blood pressure: Results from SYMPLICITY HTN-3. J Am Coll Cardiol 2014; 64: 1071-1078.
24. O’Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 2013; 31: 1731-1768.
25. Kario K, Bhatt DL, Brar S, Cohen SA, Fahy M, Bakris GL. Effect of catheter-based renal denervation on morning and nocturnal blood pressure: Insights from SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan. Hypertension 2015; 66: 1130-1137.
26. Kandzari DE, Bhatt DL, Brar S, Devireddy CM, Esler M, Fahy M, et al. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. Eur Heart J 2015; 36: 219-227.
27. Rothwell PM, Howard SC, Dolan E, O’Brien E, Dobson JE, Dahlöf B, et al. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol 2010; 9: 469-480.
28. Kario K, Bakris GL, Bhatt D. Preferential reduction in morning/ nocturnal hypertension by renal denervation for drug-resistant hypertension: A new ABPM analysis of SYMPLICITY HTN-3 and HTN-Japan. J Hypertens 2015; 33(Suppl 1): e52.
29. Mc Causland FR, McMullan CJ, Sacks FM, Forman JP. Race, plasma renin activity, and morning blood pressure surge: Results from the Dietary Approaches to Stop Hypertension trial. Am J Hypertens 2014; 27: 530-536.
30. Bhatt DL, James GD, Pickering TG, Devereux RB. Relation of arterial pressure level and variability to left ventricular geometry in normotensive and hypertensive adults. Blood Press Monit 1996; 1: 415-424.
31. Okada Y, Jarvis SS, Best SA, Edwards JG, Hendrix JM, Adams-Huet B, et al. Sympathetic neural and hemodynamic responses during cold pressor test in elderly blacks and whites. Hypertension 2016; 67: 951-958.
32. Calhoun DA, Mutinga ML, Collins AS, Wyss JM, Oparil S. Normotensive blacks have heightened sympathetic response to cold pressor test. Hypertension 1993; 22: 801-805.
33. Kario K. Obstructive sleep apnea syndrome and hypertension: Ambulatory blood pressure. Hypertens Res 2009; 32: 428-432.
34. Azizi M, Pereira H, Hamdidouche I, Gosse P, Monge M, Bobrie G, et al. Adherence to antihypertensive treatment and the blood pressure-lowering effects of renal denervation in the renal denervation for hypertension (DENERHTN) Trial. Circulation 2016; 134: 847-857.
35. Conlin PR, Gerth WC, Fox J, Roehm JB, Boccuzzi SJ. Fouryear persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other antihypertensive drug classes. Clin Ther 2001; 23: 1999-2010.
36. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010; 303: 2043-2050.
37. Jung O, Gechter JL, Wunder C, Paulke A, Bartel C, Geiger H, et al. Resistant hypertension?: Assessment of adherence by toxi cological urine analysis. J Hypertens 2013; 31: 766-774.
38. Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: Current outcomes and control in the community. JAMA 2005; 294: 466-472.
39. Ostchega Y, Yoon SS, Hughes J, Louis T. Hypertension awareness, treatment, and control--continued disparities in adults: United States, 2005-2006. NCHS Data Brief 2008; 3: 1-8.
40. Holmes JS, Arispe IE, Moy E. Heart disease and prevention: Race and age differences in heart disease prevention, treatment, and mortality. Med Care 2005; 43(Suppl): I33-I41.
41. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics--2015 update: A report from the American Heart Association. Circulation 2015; 131: e29-e322.
42. Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015; 373: 2103-2116.